Clin2
NCT07526324Likely a fitNot yet recruiting

Difelikefalin for Severe Itching in Kidney Dialysis Patients

Itching SymptomsCKD 5D, Hemodialysis

Part of Kidney & urinary, Skin clinical trials.

This trial tests a medication called difelikefalin to relieve severe itching in people on long-term kidney dialysis. Many dialysis patients experience persistent itching that affects their quality of life, and this study explores whether this drug can help.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
106 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are at least 18 years old
  • You have chronic kidney disease and have been on hemodialysis (blood-cleaning treatment) for at least 3 months
  • You experience moderate-to-severe itching (you'd rate it 4 or higher on a scale of 0–10)
  • You do not have a primary skin condition causing the itching
  • You are willing and able to sign a consent form and participate in the study

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06593392Recruiting· Phase 2
Safety of difelikefalin for itching in teens on dialysis

This trial tests a drug called difelikefalin to see if it safely reduces moderate-to-severe itching in teenagers who are on hemodialysis. Itching is common in kidney disease, and this study aims to find a new treatment option.

Chengdu
NCT07650851Not yet recruiting
New medicine for itching in kidney dialysis patients

This trial tests a new tablet called nalfurafine to help reduce severe itching that happens in people on regular kidney dialysis. If you've had itching for a while despite trying other treatments, this study may help you and contribute to better options for dialysis patients.

Beijing, Beijing Municipality
NCT07769073Not yet recruiting· Phase 4
Medicine for itching in kidney dialysis patients

This study tests a medicine called nalfurafine to see if it can reduce severe itching that many people on dialysis have. It will compare the medicine to standard care to find out if it works.

NCT07098351Recruiting
A trial for a new itchy skin medicine for people on peritoneal dialysis

This trial tests if a medication called nalfurafine hydrochloride (taken as a tablet that melts in your mouth) can help reduce moderate to severe itching in people receiving peritoneal dialysis for chronic kidney disease.

Guangzhou, Guangdong
NCT07380113Recruiting· Phase 4
Comparing two drugs for sleep in dialysis patients with itch

This trial tests if anrikefon or nalfurafine improves sleep quality in people on hemodialysis who have chronic kidney disease-related itching. It aims to find a better treatment for both itch and sleep problems.

Guangzhou, Guangdong
NCT06671535Recruiting
Dialysis filter for itching in hemodialysis patients

This study tests a special type of dialysis filter (made of PMMA) to see if it can reduce severe itching and improve quality of life for people on long-term dialysis. If you have bothersome itching that standard treatment hasn't helped, this trial might be an option for you.

Saint Petersburg

Hear when a new CKD 5D, Hemodialysis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.